BOOK
Gastroenterologic Issues in the Obese Patient, An Issue of Gastroenterology Clinics - E-Book
(2010)
Additional Information
Book Details
Abstract
Given the prevalence of obesity, any physician providing clinical care will be involved in the care of obese patients. Gastroenterologists will play an active role in the evaluation and treatment of these patients. Thereby, it is essential to fully understand the scope of the problem and the opportunities for intervention. The expert authors assembled for this issue offer expanded insight which can enhance care plans provided to this patient population. Since Dr. Johnson’s first issue published, there are several updates in this area, and the articles in this volume address those. These updates are seen in the areas of medical therapy, surgical options, and endoscopic treatments for obese patients.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Contributors | iii | ||
| Contents | v | ||
| Preface | xi | ||
| Chapter 1. The Epidemiology of Obesity | 1 | ||
| DEFINITIONS FOR OVERWEIGHT AND OBESITY | 1 | ||
| OBESITY TRENDS IN ADULTS AND CHILDREN | 2 | ||
| POSSIBLE CAUSES OF THE OBESITY EPIDEMIC | 4 | ||
| BURDEN OF ILLNESS ASSOCIATED WITH OBESITY | 5 | ||
| SUMMARY AND CONCLUSIONS | 5 | ||
| REFERENCES | 6 | ||
| Chapter 2. Prevalence and Epidemiology of Gastrointestinal Symptoms Among Normal Weight, Overweight, Obese and Extremely Obese Individuals | 9 | ||
| GASTROINTESTINAL SYMPTOMS | 10 | ||
| STUDIES EVALUATING GI SYMPTOMS AND OBESITY | 13 | ||
| SUMMARY ANALYSIS OF REPORTED STUDIES | 17 | ||
| FUTURE STUDIES: NEW QUESTIONS AND DIRECTIONS | 21 | ||
| REFERENCES | 22 | ||
| Chapter 3. Gastrointestinal Symptoms and Diseases Related to Obesity: An Overview | 23 | ||
| GASTROINTESTINAL SYMPTOMS RELATED TO OBESITY AND OBESITY TREATMENTS | 24 | ||
| GUT HORMONES AND REGULATION OF APPETITE AND SATIETY | 24 | ||
| EFFECT OF OBESITY TREATMENTS ON GASTROINTESTINAL SYMPTOMS | 28 | ||
| EFFECT OF BARIATRIC SURGERY ON GUT HORMONES | 29 | ||
| GASTROINTESTINAL SYMPTOMS ASSOCIATED WITH INCREASED BMI | 30 | ||
| GASTROINTESTINAL DISEASES RELATED TO OBESITY | 30 | ||
| REFERENCES | 32 | ||
| Chapter 4. Gastroesophageal Reflux Disease and Obesity | 39 | ||
| DIET, FOOD, AND REFLUX | 39 | ||
| SYMPTOMS | 40 | ||
| COMPLICATIONS | 41 | ||
| WEIGHT LOSS | 42 | ||
| TREATMENT: APPROACH TO THE PATIENT | 43 | ||
| SUMMARY | 43 | ||
| REFERENCES | 44 | ||
| Chapter 5. Colonic Complications of Obesity | 47 | ||
| OBESITY AND COLORECTAL NEOPLASIA | 48 | ||
| OTHER EFFECTS OF OBESITY ON THE COLON | 52 | ||
| COLORECTAL CANCER SCREENING | 53 | ||
| BOWEL PREPARATION | 53 | ||
| SURGICAL OUTCOMES AFTER LAPAROSCOPIC COLECTOMY FOR COLON CANCER | 53 | ||
| SUMMARY | 54 | ||
| REFERENCES | 54 | ||
| Chapter 6. Hepatic Complications of Obesity | 57 | ||
| HISTOPATHOLOGY AND PATHOGENESIS OF OBESITY-RELATED LIVER DISEASE | 57 | ||
| CLINICAL FEATURES AND LABORATORY ABNORMALITIES OF OBESITY-RELATED LIVER DISEASES | 58 | ||
| COMORBID CONDITIONS COMMONLY ASSOCIATED WITH OBESITY-RELATED LIVER DISEASE | 59 | ||
| PROGNOSIS OF OBESITY-RELATED LIVER DISEASE | 60 | ||
| EFFECTS OF WEIGHT LOSS AND TREATING COMORBIDITIES ON LIVER DISEASE OUTCOMES | 60 | ||
| TARGETED PHARMACOLOGIC TREATMENTS FOR OBESITY-RELATED LIVER DISEASE | 62 | ||
| SUMMARY | 63 | ||
| REFERENCES | 64 | ||
| Chapter 7. Pharmacologic Therapies for Obesity | 69 | ||
| MEDICATIONS APPROVED FOR THE TREATMENT OF OBESITY | 70 | ||
| PHENTERMINE | 71 | ||
| SIBUTRAMINE | 72 | ||
| ORLISTAT | 73 | ||
| NOVEL PHARMACOLOGIC THERAPIES | 73 | ||
| DISCREDITED MEDICATIONS | 74 | ||
| PHARMACOLOGIC TREATMENT OF DRUG-INDUCED WEIGHT GAIN | 75 | ||
| MEDICATION USE AFTER WEIGHT LOSS SURGERY | 76 | ||
| FUTURE CONSIDERATIONS | 76 | ||
| REFERENCES | 77 | ||
| Chapter 8. Preoperative Gastrointestinal Assessment Before Bariatric Surgery | 81 | ||
| PREOPERATIVE EVALUATION | 81 | ||
| SUMMARY | 84 | ||
| REFERENCES | 84 | ||
| Chapter 9. Endoscopy in the Obese Patient | 87 | ||
| ENDOSCOPY IN OBESE PATIENTS: UNIQUE CHALLENGES | 87 | ||
| ENDOSCOPY IN OBESE PATIENTS: THE POSTBARIATRIC SURGERY PATIENT | 89 | ||
| ENDOSCOPY IN OBESE PATIENTS: FUTURE ROLE OF ENDOSCOPY | 94 | ||
| SUMMARY | 94 | ||
| REFERENCES | 95 | ||
| Chapter 10. Endoscopic Retrograde Cholangiopancreatography in Patients with Roux-en-Y Anatomy | 99 | ||
| ADVANCEMENT OF DUODENOSCOPES THROUGH THE ANATOMIC ROUTE | 100 | ||
| ADVANCEMENT OF ENTEROSCOPES OR COLONOSCOPES THROUGH THE PER OS ANATOMIC ROUTE | 100 | ||
| ERPC WITH DOUBLE- OR SINGLE-BALLOON ENTEROSCOPES | 101 | ||
| ERCP THROUGH GASTROSTOMY OR JEJUNOSTOMY TRACTS | 101 | ||
| LAPAROSCOPIC-ASSISTED ERCP | 102 | ||
| CHOOSING THE BEST APPROACH | 104 | ||
| REFERENCES | 105 | ||
| Chapter 11. Postoperative Metabolic and Nutritional Complications of Bariatric Surgery | 109 | ||
| METABOLIC CONSEQUENCES OF BARIATRIC SURGERY | 111 | ||
| MACRONUTRIENTS | 113 | ||
| MICRONUTRIENTS | 113 | ||
| FAT-SOLUBLE VITAMINS | 114 | ||
| WATER-SOLUBLE VITAMINS | 116 | ||
| TRACE ELEMENTS | 118 | ||
| NUTRITIONAL CONSEQUENCES OF BARIATRIC SURGERY | 120 | ||
| REFERENCES | 122 | ||
| Chapter 12. The Surgical Treatment of Metabolic Disease and Morbid Obesity | 125 | ||
| OPERATIONS COMMONLY PERFORMED CURRENTLY | 126 | ||
| LAPAROSCOPIC ADJUSTABLE GASTRIC BANDING | 128 | ||
| BILIOPANCREATIC DIVERSION AND BILIOPANCREATIC DIVERSION WITH DUODENAL SWITCH | 129 | ||
| SLEEVE GASTRECTOMY | 130 | ||
| LESS COMMON AND HISTORICAL OPERATIONS FOR WEIGHT LOSS | 132 | ||
| SUMMARY | 132 | ||
| REFERENCES | 133 | ||
| Chapter 13. Short- and Long-Term Surgical Follow-Up of the Postbariatric Surgery Patient | 135 | ||
| DEFINITIONS | 136 | ||
| SHORT-TERM FOLLOW-UP | 136 | ||
| MEDIUM-TERM FOLLOW-UP | 139 | ||
| LONG-TERM FOLLOW-UP | 143 | ||
| SUMMARY | 145 | ||
| REFERENCES | 145 | ||
| Index | 147 |